Welcome to our dedicated page for Harte Hanks news (Ticker: HHS), a resource for investors and traders seeking the latest updates and insights on Harte Hanks stock.
Harte Hanks, Inc. reports news as a customer experience company serving clients through Revenue Solutions, Customer Care, and Fulfillment & Logistics Services. Company updates commonly cover quarterly and annual results, revenue trends by segment, EBITDA and adjusted EBITDA measures, cost controls, customer contract transitions, and operating initiatives such as Project Elevate.
Recurring developments also include customer care partnerships, data-driven marketing assets, healthcare marketing capabilities, leadership changes, and financing actions such as amendments to its asset-based revolving credit facility. Its Fulfillment & Logistics Services business includes printing, lettershop, mail optimization, logistics, transportation optimization, monitoring, and tracking for traditional and specialized mailings.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Harte Hanks, Inc. (NASDAQ:HHS) will announce its financial results for the first quarter ending March 31, 2023, on May 2, 2023, after market close. The company will host a conference call and live webcast at 4:30 p.m. EST on the same day to discuss these results.
Investors can access the webcast here or participate via phone at (888) 506-0062 in the U.S. and (973) 528-0011 internationally, using access code 483090. A replay will be available until May 16, 2023, through (877) 481-4010 from the U.S. and (919) 882-2331 internationally.
Harte Hanks is a customer experience company with a mission to deliver CX strategy and analytics, working with major brands like Pfizer and Ford.